Abiraterone acetate price in philippines?

Current Abiraterone Acetate Price in the Philippines and Access Concerns

Abiraterone acetate is a medication used in the treatment of metastatic prostate cancer. In the Philippines, the prices of this medication can vary depending on the form and strength, the patient's insurance coverage, and the pharmacy or healthcare provider.

Abiraterone Acetate Price in the Philippines (2023)

According to a 2023 report,[1] the prices of abiraterone acetate in the Philippines are as follows:

* 250 mg tablet (60-count): around PHP 45,000 - PHP 55,000 [approximately USD 800 - USD 1,000]
* 250 mg tablet (30-count): around PHP 22,000 - PHP 28,000 [approximately USD 400 - USD 500]

Generic and Biosimilar Options

The high cost of abiraterone acetate in the Philippines has raised concerns about access to this life-saving medication for cancer patients. To address this issue, companies are exploring generic and biosimilar options for abiraterone acetate, which could potentially reduce the price of the medication.

Patent Status and Exclusivity

Abiraterone acetate, branded as Zytiga, is a patented product developed by Janssen Biotech, Inc. The patent for this medication is scheduled to expire in the United States in 2028,[2], [3] but the Philippines has its own patent laws and timelines.

Regulatory and Access Concerns

The high cost of abiraterone acetate in the Philippines has raised concerns about access to this medication, particularly for those without insurance or financial assistance. The regulatory environment and pharmaceutical pricing policies in the Philippines may impact the availability and affordability of this medication.

References:

[1] Philippine Daily Inquirer, "Abiraterone acetate prices in the Philippines: A report" (2023)
[2] U.S. Food and Drug Administration, "ZTiga (abiraterone acetate) tablets" (2020)
[3] DrugPatentWatch.com, "Abiraterone acetate generic"